Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revolution Medicines Inc shares valued at $98,982 were sold by Wei Lin on Sep 16 ’25. At $45.82 per share, Wei Lin sold 2,160 shares. The insider’s holdings dropped to 88,339 shares worth approximately $3.99 million following the completion of this transaction.
Also, Kelsey Stephen Michael sold 5,367 shares, netting a total of over 245,942 in proceeds. Following the sale of shares at $45.82 each, the insider now holds 284,047 shares.
Before that, GOLDSMITH MARK A had sold 13,411 shares from its account. In a trade valued at $614,558, the insider traded Revolution Medicines Inc shares for $45.82 each. Upon closing the transaction, the insider’s holdings decreased to 13,411 shares, worth approximately $20.45 million.
Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of August 19, 2025, Piper Sandler has initiated its “an Overweight” rating for RVMD. Earlier on August 15, 2025, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for RVMD stock.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] rose 3.22% to $45.22. The stock’s lowest price that day was $44.03, but it reached a high of $45.36 in the same session. During the last five days, there has been a drop of approximately -2.21%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 1.53%.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp rise in short interest on 2025-08-29 jumping by 2.6 million shares to 16.53 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 13.93 million shares. A jump of 15.71% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.49 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.49.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 73.5 in the next 12 months, up nearly 67.77% from the previous closing price of $43.81. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 64. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On July 15, 2025, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $65.
